Technology News and Research

RSS

M.D. Peled to market Universal Detection Technology's Bio-Weapon Detection Systems in Israel

Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has received its first purchase order from the Company’s newly signed Israeli Distributor, M.D. Paled.

28 Sep 2009

Misregulation of SPAK protein may contribute to B-cell lymphoma development

A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development. Their report can be found in the October 2009 issue of the American Journal of Pathology.

28 Sep 2009

NSERC awards $5M grant to develop faster detection methods for cancer

A nanomedicine research group led by a University of Toronto chemist has received a $5-million grant from the Natural Sciences and Engineering Research Council of Canada (NSERC), giving them the green light to develop faster ways of detecting leukemia and lung cancer cells.

28 Sep 2009

Quintiles opens an expanded regional facility

To enhance service offerings throughout Europe, Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. The purpose-built facility consolidates three buildings into a single state-of-the-art complex.

28 Sep 2009

UTAS chooses ADI Blackfin processors to ensure high quality patient care

Analog Devices, Inc. (NYSE: ADI) today announced that UTAS, a provider of medical devices for patient monitoring and diagnostics, has selected ADI Blackfin® processors to ensure high-performance digital signal processing operations and robust functionality across its full line of products.

28 Sep 2009

First heart surgery using MECC system completed

MAQUET Cardiovascular announced today that Johannes Bonatti, M.D., Professor of Surgery and Director of Coronary Surgery and Advanced Coronary Interventions at the University of Maryland Heart Center in Baltimore, has completed the world's first use of the MAQUET Minimized ExtraCorporeal Circulation (MECC) system during a successful robotic and fully endoscopic heart surgery. The new cardiopulmonary bypass technology is the first major advancement in perfusion technology in the last decade. It is designed to minimize the effects of traditional heart surgery and aid in minimally-invasive heart surgery without the need to stop the patient's heart from beating.

28 Sep 2009

Researchers measure the brain activity in infants

Do infants only start to crawl once they are physically able to see danger coming? Or is it that because they are more mobile, they develop the ability to sense looming danger? According to Ruud van der Weel and Audrey van der Meer, from the Norwegian University of Science and Technology in Trondheim, infants' ability to see whether an object is approaching on a direct collision course, and when it is likely to collide, develops around the time they become more mobile. Their findings have just been published online in the Springer journal Naturwissenschaften.

27 Sep 2009

INFORMS annual meeting in San Diego from October 11th to 14th

When 4,000 experts in everything from problems with California's hospitals to a perpetual game of Monopoly come to San Diego on October 11, the city will find itself deluged not only by smart people who use math for a living but also problem solvers who tackle America's greatest threats.

26 Sep 2009

Network in Canada to develop biomaterials for treatment of eye diseases

Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.

26 Sep 2009

ProSperus, Genesis Physicians Group launch GenPro Practice Management Solutions

ProSperus, a Mequon, Wis.,-based, full-service practice management company, and Genesis Physicians Group, a Dallas-based independent physicians association (IPA), today announced the launch of GenPro Practice Management Solutions.

26 Sep 2009

Millennium Foundation announces fundraising initiative for global health

The Millennium Foundation for Innovative Finance for Health today announced MASSIVEGOOD, a new, innovative travel-related fundraising initiative that will help finance health care for the world's poor.

26 Sep 2009

NIH grants $5 million to Pittsburgh researchers

Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs.

26 Sep 2009

GenVec to receive $2.3M from NIAID for HIV vaccine candidate production

GenVec, Inc. announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its third option period (year four) under a previously announced, five-year contract with GenVec valued at up to $52 million for the production of HIV vaccines.

26 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

Accelr8 Technology concludes technical development project with Becton

Accelr8 Technology Corporation announced today that it has concluded a technical development project with Becton, Dickinson and Company (“BD”) (NYSE: BDX).

26 Sep 2009

Stem Cell Therapy International merges with Histostem

Stem Cell Therapy International, Inc. is proud to announce the execution of the Reorganization and Stock Purchase Agreement ("the Agreement") with Histostem Co., Ltd., a Korean company ("Histostem" and together with SCII, "the parties").

25 Sep 2009

Central metabolic network model of Thermotoga maritima bacterium developed

Investigators at Burnham Institute for Medical Research (Burnham), University of California, San Diego (UC San Diego), The Scripps Research Institute (TSRI), Genomics Institute of the Novartis Research Foundation (GNF) and other institutions have constructed a complete model, including three dimensional protein structures, of the central metabolic network of the bacterium Thermotoga maritima (T. maritima).

25 Sep 2009

NIH calls for identifying better methods to predict the risk of developing breast cancer

Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.

25 Sep 2009

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.

25 Sep 2009

Levin Group to develop a practice integration program for BIOLASE dental lasers

BIOLASE Technology, Inc. today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices.

25 Sep 2009